Thus, low expression of B7H3 (CPM expression, < 1.67 CPM) and high expression of BANP (CPM expression > 3.96 CPM) seem to identify a subset of patients with better outcome in the classical high-risk group of TP53 mutated or complex karyotype elderly patients, including old AML patients treated with intensive chemotherapy. This evidence concerns the gene BANP and acute myeloid leukemia.